Published by Josh White on 17th July 2024
(Sharecast News) - Johnson & Johnson's stock was in the green on Wednesday, after the pharmaceutical giant reported second-quarter earnings and sales that surpassed analysts' expectations, largely driven by its innovative medicines segment.
URL: http://www.digitallook.com/dl/news/story/34433462/...